Breakthrough Therapy for Auto-Immune Diseases; Multiple Indication Product: Completed Phase II Trial in T1D, ready to enter Phase III

Industry: BioTech

Location: Cedar Knolls, NJ

Stage: Series A+

Funding currency: Seed in progress

Financial status: RMB

Funding needed: $60M

Existing investors: Contact us to unlock more details

Favorites